| scholarly article | Q13442814 |
| P2093 | author name string | A. Sauerbrei | |
| P2860 | cites work | Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients | Q24194490 |
| Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection | Q24242853 | ||
| Maternal and neonatal herpes simplex virus infections | Q24653520 | ||
| Genital herpes | Q28262599 | ||
| Current thinking on genital herpes | Q28303928 | ||
| SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans | Q28740364 | ||
| Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States | Q33614235 | ||
| Diagnosis of genital herpes simplex virus infection in the clinical laboratory | Q33655295 | ||
| Herpes simplex virus infections | Q33948597 | ||
| Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review | Q34152197 | ||
| Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. | Q34266505 | ||
| Sexually transmitted diseases treatment guidelines, 2015. | Q34479272 | ||
| Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance | Q34479800 | ||
| A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs. | Q34501866 | ||
| Herpes simplex virus resistance to antiviral drugs | Q34531396 | ||
| Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model | Q34551511 | ||
| Safety of antiviral medication for the treatment of herpes during pregnancy. | Q34791778 | ||
| Case study: type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy | Q77828063 | ||
| Neonatal herpes simplex virus infections | Q77851190 | ||
| A double-blind study of the efficacy and safety of the ICP10deltaPK vaccine against recurrent genital HSV-2 infections | Q78437118 | ||
| Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. | Q35551858 | ||
| Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate. | Q35800862 | ||
| Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2. | Q35869527 | ||
| Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition | Q35906801 | ||
| Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection | Q36034465 | ||
| Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial | Q36306926 | ||
| Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. | Q36331074 | ||
| Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women | Q36517783 | ||
| Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay. | Q36545092 | ||
| The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections | Q36559353 | ||
| Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections | Q36682077 | ||
| Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention | Q37164885 | ||
| Selective anti-herpesvirus agents | Q38076214 | ||
| Status of prophylactic and therapeutic genital herpes vaccines | Q38196195 | ||
| Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2. | Q38598512 | ||
| Genital herpes simplex virus infections: clinical manifestations, course, and complications | Q40150591 | ||
| Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling | Q40488344 | ||
| Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. | Q40714124 | ||
| High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies | Q40812147 | ||
| 2014 UK national guideline for the management of anogenital herpes | Q41345018 | ||
| Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology | Q41371555 | ||
| Helicase-primase inhibitor pritelivir for HSV-2 infection | Q42243140 | ||
| Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays | Q42243676 | ||
| Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects | Q42927035 | ||
| Evaluation of a Novel Serology Algorithm to Detect Herpes Simplex Virus 1 or 2 Antibodies | Q43726567 | ||
| Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics | Q44275589 | ||
| Latent herpes simplex virus in spinal ganglia of mice | Q44563203 | ||
| Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. | Q44860225 | ||
| Natural history of genital herpes simplex virus type 1 infection | Q44950861 | ||
| Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture | Q45162165 | ||
| Value of herpes simplex virus type-specific serology: a case report | Q45358648 | ||
| Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. | Q45361742 | ||
| The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. | Q45378469 | ||
| A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects | Q45423435 | ||
| Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes | Q45742672 | ||
| A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group | Q45746487 | ||
| Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial | Q45759646 | ||
| Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes | Q45783219 | ||
| A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group | Q46117817 | ||
| European guideline for the management of genital herpes, 2010. | Q50525827 | ||
| Herpes revisited. Still a cause of concern. | Q51052610 | ||
| Daily stress and recurrence of genital herpes simplex. | Q52866949 | ||
| Recurrence rates in genital herpes after symptomatic first-episode infection | Q72852714 | ||
| Laboratory diagnosis of herpes zoster | Q73148575 | ||
| Neonatal herpes simplex virus infection | Q73214960 | ||
| Virological diagnosis of herpes simplex encephalitis | Q73801155 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1310-1317 | |
| P577 | publication date | 2016-12-01 | |
| P1433 | published in | Geburtshilfe und Frauenheilkunde: Ergebnisse der Forschung für die Praxis | Q26841999 |
| P1476 | title | Herpes Genitalis: Diagnosis, Treatment and Prevention | |
| P478 | volume | 76 |
| Q90464180 | Inflammatory pseudotumor associated with HSV infection of rectal vascular endothelium in a patient with HIV: a case report and literature review |
| Q90049603 | Non-HPV Perianal and Anorectal Sexually Transmitted Viral Infections |
| Q55518233 | Surgical excision of a large, verrucous, scrotal mass in a patient with HSV-2 and HIV-1 co-infection. |
Search more.